Leggi il settimanale
Cerca
Edicola digitale
+

COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

default_image

AdnKronos
  • a
  • a
  • a

Dai blog